EUBA Statement on Revised draft Delegated Act on climate-related objectives

EuropaBio Statement – Vaccine production scale up: International collaboration remains the key.

Online Roundtable Report: An EU Vision For Life Science and Biotechnology for a Healthy and Sustainable EU

Webinar Report.

Webinar Report: Measuring the Economic Footprint of the Biotechnology Industry in Europe

Webinar Report.

Rare Disease Week 2021 – Interview with Dr. Ravi Rao, Head of Research & Development, Chief Medical Officer at Sobi

Read EuropaBios interview with Dr. Ravi Rao, Head of Research & Development, Chief Medical Officer at Sobi, on the occasion of Rare Disease Week 2021.

European Health Emergency Preparedness and Response Authority (HERA) Consultation – EuropaBio’s Feedback

On February 24th, EuropaBio submitted its feedback to the HERA Consultation.

EuropaBio draft response to the IIA on European Health Data Space

EuropaBio welcomes the European Commission’s plan to begin a discussion with stakeholders to develop the EHDS.

Building a European Health Union

EuropaBio welcomes the European Health Union plan. The EU has indeed a critical role to play in public health and better crisis preparedness to address serious cross-border health threats and improving crisis management capacity.

EuropaBio Comments on the Draft Delegated Act on Climate-Related Objectives under the Taxonomy Regulation

EuropaBio comments on the draft delegated act on climate-related objectives under the Taxonomy Regulation.

Genome editing FAQ

Genome editing is an advance in biological tools with the potential for a wide range of applications.

Genome-Edited Products and Projects: Resources and Examples

This is a non-exhaustive list of over 200 genome-editing or viral vector related products and research projects, drawn from various resources and covering healthcare, industrial and agricultural biotech

The impact of COVID-19 on patients with chronic or life-threatening conditions

Read our latest blog on the impact of the pandemic on patients with chronic diseases and rare conditions around the globe.

How soon can we respond to COVID-19?

The development of a vaccine or an antiviral treatment is a long and complex process. So why are we hearing that a vaccine against COVID-19 may be ready in a year from now, or even sooner?

EuropaBio reply letter to European Patients’ Forum’s call on COVID-19

EuropaBio reply letter to EPF's call on COVID-19.

CRISPR and Coronavirus

A recent interview with Prof. Jennifer Doudna, a co-discoverer of the CRISPR-Cas9 system for genome editing, highlights potential applications of the technology to COVID-19.

Clinical Trials and Coronavirus

Check out the latest news on coronavirus clinical trials.

World Haemophilia Day – Interview with Amanda Bok (EHC)

The 30th anniversary of World Haemophilia Day helps to illustrate the importance to support the bleeding disorders community. Read our interview with Amanda Bok, CEO of the European Haemophilia Consortium (EHC) & Co-Chair of EuropaBio's Patients BioForum.

Primary Immunodeficiencies Week – Interview Johan Prevot (IPOPI)

On the occasion of World PI Week we interviewed Johan Prevot, Executive Director of the International Patient Organisation for Primary Immunodeficiencies (IPOPI).

World Haemophilia Day – Interview with Dr. Ian Winburn (Pfizer)

On the occasion of World Haemophilia Day we had the pleasure to interview Dr. Ian Winburn, Global Medical Lead within Pfizer’s Rare Disease Business Unit.

World Haemophilia Day – A Message from Paul Perrault (CSL Behring)

On the occassion of World Haemophilia Day, read a message from Paul Perreault, CEO of CSL Behring.

World Haemophilia Week – Interview with Philip Wood (Sobi)

During World Haemophilia Week, we caught up with Sobi's Head of Haematology, Philip Wood.
Become a member